Fig. 1

a. Overall survival for 111 patients with locally advanced NSCLC. b. Cumulative incidence of any progression (green-dased curve), out-of-field recurrence (blue curve), and local recurrence per patient (red-dashed curve). c. Cumulative incidence of per-lesion local recurrence for primary tumor and nodal target volumes receiving definitive radiation